標(biāo)題: Titlebook: Extracellular Vesicles in Cardiovascular and Metabolic Diseases; Junjie Xiao Book 2023 The Editor(s) (if applicable) and The Author(s), un [打印本頁(yè)] 作者: Aggrief 時(shí)間: 2025-3-21 16:32
書(shū)目名稱(chēng)Extracellular Vesicles in Cardiovascular and Metabolic Diseases影響因子(影響力)
書(shū)目名稱(chēng)Extracellular Vesicles in Cardiovascular and Metabolic Diseases影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Extracellular Vesicles in Cardiovascular and Metabolic Diseases網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Extracellular Vesicles in Cardiovascular and Metabolic Diseases網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Extracellular Vesicles in Cardiovascular and Metabolic Diseases被引頻次
書(shū)目名稱(chēng)Extracellular Vesicles in Cardiovascular and Metabolic Diseases被引頻次學(xué)科排名
書(shū)目名稱(chēng)Extracellular Vesicles in Cardiovascular and Metabolic Diseases年度引用
書(shū)目名稱(chēng)Extracellular Vesicles in Cardiovascular and Metabolic Diseases年度引用學(xué)科排名
書(shū)目名稱(chēng)Extracellular Vesicles in Cardiovascular and Metabolic Diseases讀者反饋
書(shū)目名稱(chēng)Extracellular Vesicles in Cardiovascular and Metabolic Diseases讀者反饋學(xué)科排名
作者: 助記 時(shí)間: 2025-3-21 20:48
Extracellular Vesicles in Cardiovascular and Metabolic Diseases978-981-99-1443-2Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: goodwill 時(shí)間: 2025-3-22 01:20
https://doi.org/10.1007/978-981-99-1443-2Extracellular vesicles; Cardiovascular diseases; Metabolic diseases; Cardiac aging; Therapeutic implicat作者: 補(bǔ)助 時(shí)間: 2025-3-22 08:30 作者: conduct 時(shí)間: 2025-3-22 11:40 作者: negligence 時(shí)間: 2025-3-22 13:44
Inflationsmechanismen und -ursachen, cardiovascular disease being the major cause of mortality among elderly people. The allostatic overload imposed by the accumulation of cardiac senescent cells has been suggested to play a pivotal role in the aging-related deterioration of cardiovascular function. Senescent cells exhibit intrinsic d作者: negligence 時(shí)間: 2025-3-22 21:08
Kumaraswamy Velupillai,Lionello Punzo to left ventricular aneurysm, ventricular septal defect, and mitral insufficiency. Extracellular vesicles (EVs) secreted by diverse cells in the body exert roles in cell–cell interactions and intrinsic cellular regulations. With a lipid double-layer membrane and biological components such as DNA, p作者: 巫婆 時(shí)間: 2025-3-23 00:40 作者: Graduated 時(shí)間: 2025-3-23 03:31 作者: Vulnerary 時(shí)間: 2025-3-23 06:19
https://doi.org/10.1007/978-3-540-74353-8different types of cells including platelet, monocytes, macrophages, endothelial cells, and others. It is widely accepted that both innate and adaptive immune responses are important for the initiation and progression of vascular inflammation. The cell–cell interaction constitutes an important aspec作者: Ardent 時(shí)間: 2025-3-23 12:45 作者: 拱形面包 時(shí)間: 2025-3-23 17:23
Influence and Power: A Mess Transformed? year, and it has developed into a common chronic disease that seriously affects people’s health around the world. It is an important risk factor for liver cirrhosis, liver cancer, and a variety of extrahepatic chronic diseases. Therefore, the early diagnosis and early therapy of fatty liver are imp作者: Lumbar-Stenosis 時(shí)間: 2025-3-23 21:42 作者: 不真 時(shí)間: 2025-3-23 22:25
Behaviour Under Cyclic Loading, process is related to an impairment of bone remodeling orchestrated mainly by resident bone cells, including osteoblasts, osteoclasts, osteocytes, and their progenitors. Extracellular vesicles (EVs) are nanoparticles emerging as regulatory molecules and potential biomarkers for bone loss. Although 作者: beta-cells 時(shí)間: 2025-3-24 04:38 作者: 積習(xí)已深 時(shí)間: 2025-3-24 09:59 作者: Interferons 時(shí)間: 2025-3-24 13:28 作者: flex336 時(shí)間: 2025-3-24 15:48 作者: 松果 時(shí)間: 2025-3-24 20:34
Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/e/image/319945.jpg作者: 極力證明 時(shí)間: 2025-3-25 02:06
Book 2023rdiovascular Diseases; 3) EVs in Metabolic Diseases; and 4) Therapeutic Implications. This book is useful for biologists, cardiologists, cardiovascular surgeons, endocrinologists, internists, nurses, undergraduate and graduate students in medicine and cell biology, and others interested in cardiovascular and metabolic medicine..作者: objection 時(shí)間: 2025-3-25 04:35
Book 2023 membrane vesicles released by cells and function for intercellular communication. Increasing evidence has shown that EVs play crucial roles in cardiovascular and metabolic diseases, which seriously threaten human health worldwide. The book contains four sections: 1) Extraction Methods; 2) EVs in Ca作者: 妨礙 時(shí)間: 2025-3-25 07:48
Geldwerterh?hung oder Geldentwertung?rt). The present section also discusses how to choose appropriate methods to extract EVs from tissues based on downstream analysis. This chapter will expand the horizons of EVs isolation and purification from different mediums.作者: hysterectomy 時(shí)間: 2025-3-25 13:27 作者: strdulate 時(shí)間: 2025-3-25 17:58
Updated Methods of Extracellular Vesicles Isolationrt). The present section also discusses how to choose appropriate methods to extract EVs from tissues based on downstream analysis. This chapter will expand the horizons of EVs isolation and purification from different mediums.作者: 睨視 時(shí)間: 2025-3-25 23:01
Therapeutics of Extracellular Vesicles in Cardiocerebrovascular and Metabolic Diseasesseases, including myocardial infarction, atrial fibrillation, myocardial hypertrophy, stroke, diabetes, Alzheimer’s disease, fatty liver, obesity, thyroid diseases, and osteoporosis, is discussed. Lastly, the challenges and prospects related to the preclinical and clinical application of EVs receive a particular focus.作者: Rinne-Test 時(shí)間: 2025-3-26 01:53 作者: spondylosis 時(shí)間: 2025-3-26 08:02
Inflation versus Price-Level Targetingtargets due to its biocompatible nature and low immunogenicity. In this chapter, we will first summarize the current knowledge about EVs from different cells in pathological cardiac hypertrophy. Then, we will focus on the value of EVs as therapeutic agents and biomarkers for pathological myocardial hypertrophy.作者: homocysteine 時(shí)間: 2025-3-26 11:17 作者: 縱欲 時(shí)間: 2025-3-26 14:38 作者: 小淡水魚(yú) 時(shí)間: 2025-3-26 18:36
Extracellular Vesicles and Pathological Cardiac Hypertrophytargets due to its biocompatible nature and low immunogenicity. In this chapter, we will first summarize the current knowledge about EVs from different cells in pathological cardiac hypertrophy. Then, we will focus on the value of EVs as therapeutic agents and biomarkers for pathological myocardial hypertrophy.作者: quiet-sleep 時(shí)間: 2025-3-27 00:30 作者: 情節(jié)劇 時(shí)間: 2025-3-27 04:13 作者: grovel 時(shí)間: 2025-3-27 06:11 作者: 疲勞 時(shí)間: 2025-3-27 12:00
Extracellular Vesicles and Pathological Cardiac Hypertrophytrate the underlying molecular mechanisms, many issues remain undiscovered. Recently, intercellular communication by delivering small molecules between different cell types in the progression of cardiac hypertrophy has been reported, including bioactive nucleic acids or proteins. These extracellular作者: 違法事實(shí) 時(shí)間: 2025-3-27 16:20
Extracellular Vesicles and Cardiac Aging cardiovascular disease being the major cause of mortality among elderly people. The allostatic overload imposed by the accumulation of cardiac senescent cells has been suggested to play a pivotal role in the aging-related deterioration of cardiovascular function. Senescent cells exhibit intrinsic d作者: 打包 時(shí)間: 2025-3-27 18:34
Extracellular Vesicles and Ischemic Cardiovascular Diseases to left ventricular aneurysm, ventricular septal defect, and mitral insufficiency. Extracellular vesicles (EVs) secreted by diverse cells in the body exert roles in cell–cell interactions and intrinsic cellular regulations. With a lipid double-layer membrane and biological components such as DNA, p作者: Obverse 時(shí)間: 2025-3-27 22:45 作者: exostosis 時(shí)間: 2025-3-28 05:00
Extracellular Vesicles in Coronary Artery Diseasevidence gaps remain, including pathogenesis, the most efficient diagnostic strategy, prognosis of individual patients, monitoring of therapy, and novel therapeutic strategies. These gaps could all be filled by developing novel, minimally invasive, blood-based biomarkers. Potentially, extracellular v作者: 膠狀 時(shí)間: 2025-3-28 06:35
Extracellular Vesicles and Vascular Inflammationdifferent types of cells including platelet, monocytes, macrophages, endothelial cells, and others. It is widely accepted that both innate and adaptive immune responses are important for the initiation and progression of vascular inflammation. The cell–cell interaction constitutes an important aspec作者: 分期付款 時(shí)間: 2025-3-28 10:39 作者: 太空 時(shí)間: 2025-3-28 17:29 作者: 發(fā)現(xiàn) 時(shí)間: 2025-3-28 19:50
Extracellular Vesicles and Obesitynd oncosomes. EVs are now recognized as important tools of cell-to-cell communication, allowing cells to exchange proteins, lipids, and genetic material to participate in physiological and pathological processes. It has been reported that EVs regulate host–pathogen interactions and participate in pa作者: 有權(quán)威 時(shí)間: 2025-3-28 22:59 作者: 反省 時(shí)間: 2025-3-29 04:18 作者: 分開(kāi) 時(shí)間: 2025-3-29 10:36
Therapeutics of Extracellular Vesicles in Cardiocerebrovascular and Metabolic Diseasescommunications. EVs are increasingly being recognized as the promising therapeutic agents for many diseases, including cardiocerebrovascular and metabolic diseases, due to their ability to deliver functional and therapeutical molecules. In this chapter, the biological characteristics and functions o作者: inspiration 時(shí)間: 2025-3-29 12:12
Gene Therapy of Extracellular Vesicles in Cardiovascular and Metabolic Diseaseshe cellular plasma membrane entry-system, then escaping degradation in the cytosol and in most cases, we need an efficient hacking of the nuclear membrane-system, achieving the delivery of genetic construct into the central stage of the target cells: nucleoplasm or chromosomal DNA found in this high作者: 紡織品 時(shí)間: 2025-3-29 17:50
Extracellular Vesicles and Cardiac Agingar calcification, among others. The molecular signature of these EVs is highly variable and might provide important information for the development of aging-related biomarkers. Conversely, EVs released by the stem and progenitor cells can exert a rejuvenating effect, raising the possibility of futur作者: CAGE 時(shí)間: 2025-3-29 22:39 作者: Ondines-curse 時(shí)間: 2025-3-30 00:58
Extracellular Vesicles and Hypertensionxtracellular vesicles have been proved to have the potential to be served as new biomarkers in the diagnosis, treatment, and prognosis assessment of hypertension. In the future, large multicenter cohorts are highly in demand for further verifying the sensitivity and specificity of extracellular vesi作者: venous-leak 時(shí)間: 2025-3-30 08:03 作者: Neonatal 時(shí)間: 2025-3-30 09:38
Extracellular Vesicles for Muscle Atrophy Treatmentf stem cell/progenitor cell-derived EVs in alleviating muscle atrophy, including anti-inflammatory and anti-fibrotic effects. We also discuss the clinical application of EVs in the treatment of muscle atrophy.
